Ophtacalm (Sodium Cromoglicate)

Sodium cromoglicate, the active ingredient in Ophtacalm, is a mast cell stabilizer presented as a topical ophthalmic solution for ocular use. It helps manage allergic eye conditions and other mast‑cell‑mediated ocular responses in adults and children. GNH USA supplies Ophtacalm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ophtacalm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ophtacalm is a mast cell stabilizer that acts on allergic and inflammatory pathways of the eye.

- Allergic conjunctivitis: reduces ocular itching, redness and tearing. - Vernal keratoconjunctivitis: helps control chronic inflammation and photophobia. - Seasonal allergic eye disease: alleviates symptoms during pollen seasons. - Post‑surgical ocular inflammation: supports reduction of inflammation after eye surgery.

Adverse reactions to Ophtacalm are generally mild and related to local ocular tolerance.

Common Side Effects: - Temporary stinging or burning sensation on instillation. - Mild eye irritation or foreign‑body sensation. - Transient blurred vision. - Mild conjunctival hyperemia. - Slight increase in tear production.

Serious or Rare Side Effects: - Persistent ocular irritation or pain. - Significant visual acuity changes. - Allergic contact dermatitis of the eyelid skin. - Severe hypersensitivity reaction (e.g., angio‑edema). - Secondary ocular infection. - Development of corneal ulceration.

When using Ophtacalm, follow these safety considerations:

- Avoid contact with contact lenses: remove lenses before instillation and wait before reinserting. - Monitor for allergic reactions: discontinue if severe irritation or rash develops. - Use with caution in patients with pre‑existing ocular surface disease. - Do not exceed recommended frequency: follow prescriber instructions. - Store at ambient temperature: keep in the original container, protect from direct sunlight and moisture.

Ophtacalm may interact with other ophthalmic preparations; awareness of potential combinations is important.

Major Interactions (Avoid): - Concurrent use with topical corticosteroids: may mask signs of infection. - Use with ocular antihistamines: additive local irritation.

Moderate Interactions (Monitor Closely): - Combination with other mast‑cell stabilisers: limited additional benefit. - Use with preservative‑rich eye drops: increased risk of ocular surface toxicity. - Interaction with systemic antihistamines: minimal systemic effect but monitor patient comfort.